{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:56:12Z","timestamp":1765961772878,"version":"build-2065373602"},"reference-count":250,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Chronic lymphocytic leukemia, in spite of recent advancements, is still an incurable disease; the majority of patients eventually acquire resistance to treatment through relapses. In all subtypes of chronic lymphocytic leukemia, the disruption of normal B-cell homeostasis is thought to be mostly caused by the absence of apoptosis. Consequently, apoptosis induction is crucial to the management of this illness. Damaged biological components can accumulate as a result of the oxidation of intracellular lipids, proteins, and DNA by reactive oxygen species. It is possible that cancer cells are more susceptible to apoptosis because of their increased production of reactive oxygen species. An excess of reactive oxygen species can lead to oxidative stress, which can harm biological elements like DNA and trigger apoptotic pathways that cause planned cell death. In order to upset the balance of oxidative stress in cells, recent therapeutic treatments in chronic lymphocytic leukemia have focused on either producing reactive oxygen species or inhibiting it. Examples include targets created in the field of nanomedicine, natural extracts and nutraceuticals, tailored therapy using biomarkers, and metabolic targets. Current developments in the complex connection between apoptosis, particularly ferroptosis and its involvement in epigenomics and alterations, have created a new paradigm.<\/jats:p>","DOI":"10.3390\/antiox13040475","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T08:22:44Z","timestamp":1713342164000},"page":"475","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Potential New Therapies \u201cROS-Based\u201d in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis"],"prefix":"10.3390","volume":"13","author":[{"given":"Raffaele","family":"Sciaccotta","sequence":"first","affiliation":[{"name":"Hematology Unit, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Gangemi","sequence":"additional","affiliation":[{"name":"Allergy and Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppa","family":"Penna","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Giordano","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8089-7449","authenticated-orcid":false,"given":"Giovanni","family":"Pioggia","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR), 98164 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-8239","authenticated-orcid":false,"given":"Alessandro","family":"Allegra","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/S2352-3026(19)30253-4","article-title":"Tumour Lysis Syndrome in Patients with Chronic Lymphocytic Leukaemia Treated with BCL-2 Inhibitors: Risk Factors, Prophylaxis, and Treatment Recommendations","volume":"7","author":"Tambaro","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cyto.b.21595","article-title":"Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project","volume":"94","author":"Rawstron","year":"2018","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa2114110","article-title":"Mechanisms of Resistance to Noncovalent Bruton\u2019s Tyrosine Kinase Inhibitors","volume":"386","author":"Wang","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","article-title":"Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia","volume":"20","author":"Kikushige","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survivalin chronic lymphocytic leukemia","volume":"343","author":"Stilgenbauer","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","article-title":"Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: A randomised, open-label, phase 3 trial","volume":"376","author":"Hallek","year":"2010","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","article-title":"Molecular map of chronic lymphocytic leukemia and its impact on outcome","volume":"54","author":"Knisbacher","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","article-title":"Live or let die: The cell\u2019s response to p53","volume":"2","author":"Vousden","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/leu.2010.208","article-title":"TP53 mutation profile in chronic lymphocytic leukemia: Evidence for a disease specific profile from a comprehensive analysis of 268 mutations","volume":"24","author":"Zenz","year":"2010","journal-title":"Leukemia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3109\/10428194.2011.631638","article-title":"Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia","volume":"53","author":"Seiffert","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2141.2012.09191.x","article-title":"Mimicking the tumour microenvironment: Three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells","volume":"158","author":"Hamilton","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood-2011-06-338855","article-title":"B-cell receptor signaling in chronic lymphocytic leukemia","volume":"118","author":"Stevenson","year":"2011","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0301-472X(00)00144-2","article-title":"Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: Costimulation with IL-2 results in a highly immunogenic phenotype","volume":"28","author":"Decker","year":"2000","journal-title":"Exp. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/bjh.12219","article-title":"Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls","volume":"160","author":"Dyer","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1182\/blood-2008-08-173310","article-title":"Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia","volume":"113","author":"Vogler","year":"2009","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1158\/1078-0432.CCR-16-0955","article-title":"Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia","volume":"23","author":"Roberts","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/bcmd.2000.0372","article-title":"Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivo","volume":"27","author":"Schmitt","year":"2001","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/2040620716655350","article-title":"The potential of venetoclax (ABT-199) in chronic lymphocytic leukemia","volume":"7","author":"Itchaki","year":"2016","journal-title":"Ther. Adv. Hematol."},{"key":"ref_24","first-page":"1055","article-title":"Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship between p53 mutation and bcl-2\/bax proteins in drug resistance","volume":"12","author":"Thomas","year":"1996","journal-title":"Oncogene"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V91.9.3379","article-title":"Expression of apoptotis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses","volume":"91","author":"Kitada","year":"1998","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","article-title":"The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia","volume":"24","author":"Beekman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","article-title":"Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia","volume":"26","author":"Landau","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/leu.2014.196","article-title":"Recurrent mutations refine prognosis in chronic lymphocytic leukemia","volume":"29","author":"Baliakas","year":"2015","journal-title":"Leukemia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","article-title":"Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"ref_33","unstructured":"Gale, R.P., and Rai, K.R. (1987). Chronic Lymphocytic Leukemia: Recent Progress and Future Directions, Alan R. Liss."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hon.2900060103","article-title":"Treatment of early chronic lymphocytic leukemia: Intermittent chlorambucil versus observation","volume":"6","author":"Shustik","year":"1988","journal-title":"Hematol. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"CLL trialists collaborative group (1999). Chemotherapeutic options in chronic lymphocytic leukemia: A meta-analysis of the randomized trials. J. Natl. Cancer Inst., 91, 861\u2013868.","DOI":"10.1093\/jnci\/91.10.861"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1815281","article-title":"Venetoclax and obinutuzumab in patients with CLL and coexisting conditions","volume":"380","author":"Fischer","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s10020-018-0001-1","article-title":"Critical molecular pathways in CLL therapy","volume":"24","author":"Ferrer","year":"2018","journal-title":"Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cel. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.7150\/jca.54699","article-title":"Dual role of reactive oxygen species and their application in cancer therapy","volume":"12","author":"Huang","year":"2021","journal-title":"J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10495-017-1424-9","article-title":"Induction of reactive oxygen species: An emerging approach for cancer therapy","volume":"22","author":"Zou","year":"2017","journal-title":"Apoptosis"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kumari, S., Badana, A.K., Mohan, G.M., Shailender, G., and Malla, R.R. (2018). Reactive oxygen species: A key constituent in cancer survival. Biomark. Insights, 13.","DOI":"10.1177\/1177271918755391"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Srinivas, U.S., Tan, B.W.Q., Vellayappan, B.A., and Jeyasekharan, A.D. (2019). ROS and the DNA damage response in cancer. Redox Biol., 25.","DOI":"10.1016\/j.redox.2018.101084"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2019.03.020","article-title":"Reactive oxygen species and cancer: A complex interaction","volume":"452","author":"Saikolappan","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: The bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_47","first-page":"3945","article-title":"Reactive oxygen species in cancer: Current findings and future directions","volume":"2","author":"Article","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.procbio.2020.09.032","article-title":"A paradoxical role of reactive oxygen species in cancer signaling pathway: Physiology and pathology","volume":"100","author":"Ramalingam","year":"2021","journal-title":"Process Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41423-022-00902-0","article-title":"Redox regulation of the immune response","volume":"19","author":"Morris","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"635021","DOI":"10.3389\/fimmu.2021.635021","article-title":"Reactive Oxygen Species in Autoimmune Cells: Function, Differentiation, and Metabolism","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wang, H., Jiang, H., Van De Gucht, M., and De Ridder, M. (2019). Hypoxic radioresistance: Can ROS be the key to overcome it?. Cancers, 11.","DOI":"10.3390\/cancers11010112"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Howard, D., Sebastian, S., Le, Q.V.C., Thierry, B., and Kempson, I. (2020). Chemical mechanisms of nanoparticle radiosensitization and radioprotection: A review of structure-function relationships influencing reactive oxygen species. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020579"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/ars.2012.4529","article-title":"Reactive oxygen species in cancer stem cells","volume":"16","author":"Shi","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5047168","DOI":"10.1155\/2017\/5047168","article-title":"ROS and oxidative stress in stem cells","volume":"2017","author":"Cie","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Allegra, A., Pioggia, G., Tonacci, A., Musolino, C., and Gangemi, S. (2020). Oxidative Stress and Photodynamic Therapy of Skin Cancers: Mechanisms, Challenges and Promising Developments. Antioxidants, 9.","DOI":"10.3390\/antiox9050448"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcvm.2018.00009","article-title":"Cardiotoxicity of Anticancer Therapeutics","volume":"5","author":"Dong","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3322\/caac.21341","article-title":"Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.cdd.4400959","article-title":"Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line","volume":"9","author":"Armstrong","year":"2002","journal-title":"Cell Death Differ."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ajmg.1398","article-title":"Mitochondria, oxygen free radicals, and apoptosis","volume":"106","author":"Raha","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00280-003-0726-5","article-title":"Intrinsic oxidative stress in cancer cells: A biochemical basis for therapeutic selectivity","volume":"53","author":"Hileman","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_61","first-page":"566","article-title":"Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: Enhancement of apoptosis by manipulation of cellular redox state","volume":"8","author":"Gartenhaus","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1182\/blood.V98.3.805","article-title":"Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells","volume":"98","author":"Grad","year":"2001","journal-title":"Blood"},{"key":"ref_63","first-page":"3658","article-title":"Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed\/refractory multiple myeloma","volume":"8","author":"Bahlis","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood.V98.9.2771","article-title":"Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species","volume":"98","author":"Bellosillo","year":"2001","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcdb.2014.07.013","article-title":"Necroptosis in health and diseases","volume":"35","author":"Zhou","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: An ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/cdd.2016.8","article-title":"Cancer therapy in the necroptosis era","volume":"23","author":"Su","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1007\/s00018-020-03536-5","article-title":"The multifaceted role of reactive oxygen species in tumorigenesis","volume":"77","author":"Kirtonia","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.trecan.2017.03.002","article-title":"Necroptosis and Cancer","volume":"3","author":"Najafov","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.celrep.2016.03.037","article-title":"Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity","volume":"15","author":"Aaes","year":"2016","journal-title":"Cell Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.18632\/oncotarget.3249","article-title":"RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1\u03b1 release, and efficient paracrine dendritic cell activation","volume":"6","author":"Schmidt","year":"2015","journal-title":"Oncotarget"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.redox.2018.09.007","article-title":"Curcumol induces RIPK1\/RIPK3 complex-dependent necroptosis via JNK1\/2-ROS signaling in hepatic stellate cells","volume":"19","author":"Jia","year":"2018","journal-title":"Redox Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"14329","DOI":"10.1038\/ncomms14329","article-title":"RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00432-017-2464-9","article-title":"ROS-modulated therapeutic approaches in cancer treatment","volume":"143","author":"Raza","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Hsu, S.K., Chang, W.T., Lin, I.L., Chen, Y.F., Padalwar, N.B., Cheng, K.C., Teng, Y.N., Wang, C.H., and Chiu, C.C. (2020). The Role of Necroptosis in ROS-Mediated Cancer Therapies and Its Promising Applications. Cancers, 12.","DOI":"10.3390\/cancers12082185"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","article-title":"Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells","volume":"3","author":"Dolma","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature05859","article-title":"RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","article-title":"Glutathione Peroxidase 4 Senses and Translates Oxidative Stress into 12\/15-Lipoxygenase Dependent- and AIF-Mediated Cell Death","volume":"8","author":"Seiler","year":"2008","journal-title":"Cell Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0005-2760(82)90150-3","article-title":"Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides","volume":"710","author":"Ursini","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","article-title":"The chemical basis of ferroptosis","volume":"15","author":"Conrad","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting Ferroptosis to Iron Out Cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1172\/JCI99032","article-title":"Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma","volume":"128","author":"Hassannia","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: Past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: A novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1158\/1078-0432.CCR-11-2113","article-title":"ON 01910.Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K\/AKT inhibition and induction of oxidative stress","volume":"18","author":"Chapman","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells byROS-mediated mechanisms: A radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood-2008-04-149815","article-title":"Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism","volume":"112","author":"Trachootham","year":"2008","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1093\/nar\/gkq212","article-title":"Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis","volume":"38","author":"Malhotra","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20101695","article-title":"Molecular targets of oxidative stress","volume":"434","author":"Avery","year":"2011","journal-title":"Biochem. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.436407","article-title":"HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates","volume":"21","author":"Boyault","year":"2007","journal-title":"Genes Dev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4161\/cc.7.1.5186","article-title":"HDAC6 a new cellular stress surveillance factor","volume":"7","author":"Matthias","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress","volume":"115","author":"Kawaguchi","year":"2003","journal-title":"Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1158\/1535-7163.MCT-09-0988","article-title":"Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells","volume":"9","author":"Rao","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1158\/0008-5472.CAN-08-0644","article-title":"Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nchembio.670","article-title":"Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90","volume":"7","author":"Moulick","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2008-03-143644","article-title":"HDAC6 inhibition enhances 17-AAG-mediated abrogation of HSP90 Chaper-one function in human leukemia cells","volume":"112","author":"Rao","year":"2008","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1182\/blood-2005-03-1099","article-title":"ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: Inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia","volume":"106","author":"Castro","year":"2005","journal-title":"Blood"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1038\/sj.leu.2403545","article-title":"Increased mitochondrial biogenesis in primary leukemia cells: The role of endogenous nitric oxide and impact on sensitivity to fludarabine","volume":"18","author":"Carew","year":"2004","journal-title":"Leukemia"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1182\/blood-2013-10-532200","article-title":"Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia","volume":"123","author":"Jitschin","year":"2014","journal-title":"Blood"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ncb2432","article-title":"Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia","volume":"14","author":"Zhang","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrc.2017.121","article-title":"Targeting B cell receptor signalling in cancer: Preclinical and clinical advances","volume":"18","author":"Burger","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/leu.2017.11","article-title":"Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood","volume":"31","author":"Herndon","year":"2017","journal-title":"Leukemia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJMra1908213","article-title":"Treatment of chronic lymphocytic leukemia","volume":"383","author":"Burger","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1200\/JCO.2007.15.4393","article-title":"Novel insights in chronic lymphocytic leukemia: Are we getting closer to understanding the pathogenesis of the disease?","volume":"26","author":"Ghia","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2141.1989.tb04290.x","article-title":"Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro","volume":"71","author":"Collins","year":"1989","journal-title":"Br. J. Haematol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2141.1996.00305.x","article-title":"Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro","volume":"92","author":"Panayiotidis","year":"1996","journal-title":"Br. J. Haematol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","article-title":"High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation","volume":"113","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y","article-title":"Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4\u00fe, CD40L\u00fe T cells by producing CCL22","volume":"32","author":"Ghia","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1182\/blood-2012-11-467670","article-title":"IL-21 and CD40L signals from autologous T cells can induce antigen independent proliferation of CLL cells","volume":"122","author":"Pascutti","year":"2013","journal-title":"Blood"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.12401","article-title":"Enhancement of CD154\/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia","volume":"162","author":"Ahearne","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2141.2007.06717.x","article-title":"CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia","volume":"138","author":"Willimott","year":"2007","journal-title":"Br. J. Haematol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2141.1999.01642.x","article-title":"Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia","volume":"106","author":"Kitada","year":"1999","journal-title":"Br. J. Haematol."},{"key":"ref_118","first-page":"329","article-title":"Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand","volume":"25","author":"Buske","year":"1997","journal-title":"Exp. Hematol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41375-019-0513-x","article-title":"Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL","volume":"34","author":"Yosifov","year":"2020","journal-title":"Leukemia"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2014-10-607036","article-title":"Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling","volume":"125","author":"Jitschin","year":"2015","journal-title":"Blood"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1128\/MCB.23.23.8576-8585.2003","article-title":"Influence of induced reactive oxy-gen species in p53-mediated cell fate decisions","volume":"23","author":"Macip","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"13658","DOI":"10.1074\/jbc.M109.062562","article-title":"Protection of cells in physiological oxygen tensions against DNA damage-induced apoptosis","volume":"285","author":"Carrera","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0024-3205(96)00479-1","article-title":"p53 Phosphorylation: Biochemical and functional consequences","volume":"60","author":"Milczarek","year":"1997","journal-title":"Life Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1158\/0008-5472.CAN-16-0843","article-title":"Posttranscriptional Upregulation of p53 by Reactive Oxygen Species in Chronic Lymphocytic Leukemia","volume":"76","author":"Samuel","year":"2016","journal-title":"Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmed.2006.07.007","article-title":"DNA damage-induced cell death by apoptosis","volume":"12","author":"Roos","year":"2006","journal-title":"Trends Mol. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"34277","DOI":"10.1074\/jbc.274.48.34277","article-title":"Localization of a portion of extranuclear ATM to peroxisomes","volume":"274","author":"Watters","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1038\/sj.emboj.7600455","article-title":"Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A","volume":"23","author":"Goodarzi","year":"2004","journal-title":"EMBO J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1200\/JCO.2007.11.2649","article-title":"Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion","volume":"25","author":"Austen","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2011-08-373639","article-title":"Mitochondrial dysfunction in ataxia-telangiectasia","volume":"119","author":"Maclean","year":"2012","journal-title":"Blood"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.1192912","article-title":"ATM activation by oxidative stress","volume":"330","author":"Guo","year":"2010","journal-title":"Science"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/emboj.2010.330","article-title":"ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair","volume":"30","author":"Cosentino","year":"2011","journal-title":"EMBO J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1101\/gad.1223504","article-title":"Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta","volume":"18","author":"Li","year":"2004","journal-title":"Genes Dev."},{"key":"ref_134","first-page":"1076","article-title":"Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants","volume":"100","author":"Agathanggelou","year":"2015","journal-title":"Haematologica"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"12727","DOI":"10.1093\/nar\/gkaa1110","article-title":"Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism","volume":"48","author":"Chong","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/nm.3247","article-title":"BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint","volume":"19","author":"Swaminathan","year":"2013","journal-title":"Nat. Med."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Chi, V.L.D., Garaud, S., De Silva, P., Thibaud, V., Stamatopoulos, B., Berehad, M., Gu-Trantien, C., Krayem, M., Duvillier, H., and Lodewyckx, J.N. (2019). Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5276-2"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","article-title":"Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis","volume":"122","author":"Giorgio","year":"2005","journal-title":"Cell"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/46311","article-title":"The p66shc adaptor protein controls oxidative stress response and life span in mammals","volume":"402","author":"Migliaccio","year":"1999","journal-title":"Nature"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Pellegrini, M., Finetti, F., Petronilli, V., Ulivieri, C., Giusti, F., Lupetti, P., Giorgio, M., Pelicci, P.G., Bernardi, P., and Baldari, C.T. (2007). p66SHC promotes T cell apoptosis by inducing mitochondrial dysfunction and impaired Ca2+ homeostasis. Cell Death Differ.","DOI":"10.1038\/sj.cdd.4401997"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/MCB.24.4.1747-1757.2004","article-title":"p66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells","volume":"24","author":"Pacini","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s10495-011-0663-4","article-title":"p66Shc-dependent apoptosis requires Lck and CamKII activity","volume":"17","author":"Patrussi","year":"2012","journal-title":"Apoptosis"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1182\/blood-2009-08-239244","article-title":"Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia","volume":"115","author":"Capitani","year":"2010","journal-title":"Blood"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41388-017-0066-2","article-title":"p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from \u03b2-arrestin at early endosomes","volume":"37","author":"Patrussi","year":"2018","journal-title":"Oncogene"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1182\/blood-2012-04-425959","article-title":"S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis","volume":"120","author":"Capitani","year":"2012","journal-title":"Blood"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e1068","DOI":"10.1038\/cddis.2014.44","article-title":"Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc","volume":"5","author":"Patrussi","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1158\/0008-5472.CAN-15-0986","article-title":"Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia","volume":"75","author":"Patrussi","year":"2015","journal-title":"Cancer Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3324\/haematol.2018.209981","article-title":"p66Shc deficiency in the E\u03bc-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape","volume":"104","author":"Patrussi","year":"2019","journal-title":"Haematologica"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1182\/blood-2016-04-709519","article-title":"Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4\/SDF-1 axis","volume":"128","author":"Pavlasova","year":"2016","journal-title":"Blood"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3892\/ol.2014.2817","article-title":"Prognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximab","volume":"9","author":"DERosa","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.clinbiochem.2011.08.1149","article-title":"Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemia","volume":"44","author":"Musolino","year":"2011","journal-title":"Clin. Biochem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s12032-010-9561-9","article-title":"MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: An impact on susceptibility and prognosis","volume":"28","author":"Penna","year":"2011","journal-title":"Med. Oncol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/25785826.2019.1700747","article-title":"Oxidative stress in CLL patients leads to activation of Th9 cells: An experimental and comprehensive survey","volume":"43","author":"Sabry","year":"2020","journal-title":"Immunol. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/ejh.12918","article-title":"Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia","volume":"99","author":"Vitale","year":"2017","journal-title":"Eur. J. Haematol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/10428194.2018.1509317","article-title":"Oxidative stress in chronic lymphocytic leukemia: Still a matter of debate","volume":"60","author":"Seneca","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_157","first-page":"237","article-title":"Effects of the bcr\/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro","volume":"6","author":"Svingen","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1096\/fasebj.6.14.1426765","article-title":"Tyrphostins: Tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction","volume":"6","author":"Levitzki","year":"1992","journal-title":"FASEB J."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.onc.1207248","article-title":"Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1\/MEK\/ERK- and AKT-dependent process","volume":"23","author":"Yu","year":"2004","journal-title":"Oncogene"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2003-02-0562","article-title":"Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells","volume":"102","author":"Chandra","year":"2003","journal-title":"Blood"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00280-003-0668-y","article-title":"Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and\/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines","volume":"52","author":"Avramis","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00280-002-0507-6","article-title":"In vitro and in vivo anticancer evaluations of the novel tyrosine kinase inhibitor NSC 680410","volume":"50","author":"Avramis","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1182\/blood-2004-06-2205","article-title":"Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine","volume":"105","author":"Shanafelt","year":"2005","journal-title":"Blood"},{"key":"ref_164","first-page":"1287","article-title":"The efficacy and toxicity of bendamustine in recurrent multiple myeloma after high-dose chemotherapy","volume":"90","author":"Knop","year":"2005","journal-title":"Haematologica"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.cad.0000175587.31940.19","article-title":"Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): A phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC","volume":"16","author":"Chernozemsky","year":"2005","journal-title":"Anti-Cancer Drugs"},{"key":"ref_166","first-page":"1357","article-title":"Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: Results of a phase I\/II study of the German CLL Study Group","volume":"90","author":"Bergmann","year":"2005","journal-title":"Haematologica"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00066-007-1597-1","article-title":"Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck","volume":"183","author":"Bottke","year":"2007","journal-title":"Strahlenther. Onkol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/sonc.2002.34877","article-title":"Bendamustine in the treatment of non-Hodgkin\u2019s lymphoma: Results and future perspectives","volume":"29","author":"Rummel","year":"2002","journal-title":"Semin. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00280-006-0331-5","article-title":"Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride","volume":"59","author":"Teichert","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/sj.leu.2402651","article-title":"In vitro evaluation of bendamustine induced apoptosis in Bchronic lymphocytic leukemia","volume":"16","author":"Schwanen","year":"2002","journal-title":"Leukemia"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20061552","article-title":"Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction","volume":"203","author":"Erlacher","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2005-05-2091","article-title":"The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status","volume":"107","author":"Roue","year":"2006","journal-title":"Blood"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1126\/science.1118232","article-title":"Apoptosis. p53 and PUMA: A deadly duo","volume":"309","author":"Vousden","year":"2005","journal-title":"Science"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1158\/0008-5472.CAN-05-0686","article-title":"Differential regulation of noxa in normalmelanocytes and melanoma cells by proteasome inhibition: Therapeutic implications","volume":"65","author":"Fernandez","year":"2005","journal-title":"Cancer Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1158\/0008-5472.CAN-05-0676","article-title":"Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells","volume":"65","author":"Qin","year":"2005","journal-title":"Cancer Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10495-006-0020-1","article-title":"Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours","volume":"12","author":"Armstrong","year":"2007","journal-title":"Apoptosis"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.1158\/1078-0432.CCR-08-0388","article-title":"Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling","volume":"14","author":"Milpied","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/ijc.22480","article-title":"Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells","volume":"120","author":"Li","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"16105","DOI":"10.1074\/jbc.M611115200","article-title":"Caspase inhibition sensitizes inhibitor of NF-nB kinase h-deficient fibro-blasts to caspase-independent cell death via the generation of reactive oxygen species","volume":"282","author":"May","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/jm00281a001","article-title":"Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes","volume":"15","author":"Sutton","year":"1972","journal-title":"J. Med. Chem."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","article-title":"Auranofin: Repurposing an old drug for a golden new age","volume":"15","author":"Roder","year":"2015","journal-title":"Drugs R D"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2004.04.020","article-title":"Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN\u2019s lipid phosphatase activity and membrane binding: A mechanism for the functional loss of PTEN\u2019s tumor suppressor activity","volume":"429","author":"Meuillet","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00280-019-03912-4","article-title":"The thioredoxin system and cancer therapy: A review","volume":"84","author":"Mohammadi","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12672-021-00439-0","article-title":"The gold complex auranofin: New perspectives for cancer therapy","volume":"12","author":"Abdalbari","year":"2021","journal-title":"Discov. Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","article-title":"Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia","volume":"74","author":"Fiskus","year":"2014","journal-title":"Cancer Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0091-679X(01)66017-5","article-title":"The (Holey) study of mitochondria in apoptosis","volume":"66","author":"Waterhouse","year":"2001","journal-title":"Methods Cell Biol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ddmod.2007.10.005","article-title":"Models of reactive oxygen species in cancer","volume":"4","author":"Lu","year":"2007","journal-title":"Drug Discov. Today Dis. Models"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjc.2015.85","article-title":"Mitochondrial apoptosis: Killing cancer using the enemy within","volume":"112","author":"Lopez","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3892\/ijmm.2013.1571","article-title":"Acacetin (5, 7-dihydroxy-4\u2032-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-kB\/Akt signaling in prostate cancer cells","volume":"33","author":"Kim","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.2147\/DDDT.S275148","article-title":"Acacetin Induces Apoptosis in Human Osteosarcoma Cells by Modulation of ROS\/JNK Activation","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1080\/01635581.2016.1235717","article-title":"Selective Anticancer Activity of Acacetin Against Chronic Lymphocytic Leukemia Using Both In Vivo and In Vitro Methods: Key Role of Oxidative Stress and Cancerous Mitochondria","volume":"68","author":"Salimi","year":"2016","journal-title":"Nutr. Cancer"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Gao, B., Peng, C., Lin, B., Chen, Q., Zhang, J., and Shi, Q. (2017). Screening and validation of highly-efficient insecticidal conotoxins from a transcriptome-based dataset of Chinese tubular cone snail. Toxins, 9.","DOI":"10.3390\/toxins9070214"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Gao, B., Peng, C., Yang, J., Yi, Y., Zhang, J., and Shi, Q. (2017). Cone snails: A big store of conotoxins for novel drug discovery. Toxins, 9.","DOI":"10.3390\/toxins9120397"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Fu, Y., Li, C., Dong, S., Wu, Y., Zhangsun, D., and Luo, S. (2018). Discovery methodology of novel conotoxins from Conus species. Mar. Drugs, 16.","DOI":"10.3390\/md16110417"},{"key":"ref_195","first-page":"49","article-title":"Persian Gulf Snail Crude Venom (Conus textile): A potential source of anti-cancer therapeutic agents for glioblastoma through mitochondrial-mediated apoptosis","volume":"21","author":"Salimi","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.31557\/APJCP.2021.22.5.1523","article-title":"Cytotoxicity Studies of the Crude venom and Fractions of Persian Gulf Snail (Conus textile) on Chronic Lymphocytic Leukemia and Normal Lymphocytes","volume":"22","author":"Salimi","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11864-005-0033-y","article-title":"Motexafin gadolinium induces oxidative stress and apoptosis in hematologic malignancies","volume":"6","author":"Evens","year":"2005","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: A target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.leu.2403398","article-title":"A sustained activation of PI3K\/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells","volume":"18","author":"Vargas","year":"2004","journal-title":"Leukemia"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3109\/10428194.2011.569962","article-title":"Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1","volume":"52","author":"Herishanu","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2003.01.149","article-title":"Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia","volume":"21","author":"Raffoux","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_202","first-page":"155","article-title":"The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells","volume":"5","author":"Shen","year":"2000","journal-title":"Int. J. Mol. Med."},{"key":"ref_203","first-page":"3065","article-title":"Arsenic trioxide-mediated growth inhibition in MC\/CAR myeloma cells via cell cycle arrest in association with induction of cyclindependent kinase inhibitor, p21, and apoptosis","volume":"60","author":"Park","year":"2000","journal-title":"Cancer Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1182\/blood-2002-08-2512","article-title":"Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents","volume":"101","author":"Zhou","year":"2003","journal-title":"Blood"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/sj.leu.2401900","article-title":"Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis","volume":"14","author":"Kitamura","year":"2000","journal-title":"Leukemia"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1038\/sj.onc.1208868","article-title":"Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway","volume":"24","author":"Scholz","year":"2005","journal-title":"Oncogene"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/sj.onc.1208233","article-title":"Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway","volume":"24","author":"Scholz","year":"2005","journal-title":"Oncogene"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood-2002-10-3231","article-title":"Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2\/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2\/TRAIL","volume":"101","author":"Liu","year":"2003","journal-title":"Blood"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00109-008-0314-6","article-title":"Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13","volume":"86","author":"Merkel","year":"2008","journal-title":"J. Mol. Med."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V97.1.256","article-title":"Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: Correlation with phenotypic characteristics and outcome","volume":"97","author":"Fayad","year":"2001","journal-title":"Blood"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0006-291X(92)91845-H","article-title":"Induction of Mn-superoxide dismutase by tumor necrosis factor, interleukin-1 and interleukin-6 in human hepatoma cells","volume":"182","author":"Ono","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.taap.2006.09.020","article-title":"Contributions of reactive oxygen species and mitogen-activated protein kinase signaling in arsenite-stimulated hemeoxygenase-1 production","volume":"218","author":"Cooper","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2174\/1389450111009011551","article-title":"Heme oxygenase-1 in tumor biology and therapy","volume":"11","author":"Was","year":"2010","journal-title":"Curr. Drug Targets."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1006\/bbrc.1998.9363","article-title":"Human lymphocyte heme oxygenase 1 as a response biomarker to inorganic arsenic","volume":"250","author":"Menzel","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jcb.22155","article-title":"Redox-sensitive regulation of gene expression in human primary macrophages exposed to inorganic arsenic","volume":"107","author":"Bourdonnay","year":"2009","journal-title":"J. Cell Biochem."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000086044","article-title":"Cytoprotective effects of heme oxygenase in acute renal failure","volume":"148","author":"Akagi","year":"2005","journal-title":"Contrib. Nephrol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1189\/jlb.0705363","article-title":"Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage: Up-regulation of estrogen receptor-{beta}-dependent HO-1","volume":"79","author":"Yu","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"83359","DOI":"10.18632\/oncotarget.13091","article-title":"Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"(2009). \u2018Plenty of room\u2019 revisited. Nat. Nanotechnol., 4, 781.","DOI":"10.1038\/nnano.2009.356"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Patra, J.K., Das, G., Fraceto, L.F., Campos, E.V.R., Rodriguez-Torres, M.D.P., Acosta-Torres, L.S., Diaz-Torres, L.A., Grillo, R., Swamy, M.K., and Sharma, S. (2018). Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol., 16.","DOI":"10.1186\/s12951-018-0392-8"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40580-019-0193-2","article-title":"Current trends and challenges in cancer management and therapy using designer nanomaterials","volume":"6","author":"Navya","year":"2019","journal-title":"Nano Converg."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-019-0068-3","article-title":"Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles","volume":"4","author":"Singh","year":"2019","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"e19896","DOI":"10.1016\/j.heliyon.2023.e19896","article-title":"Exploring novel strategies to improve anti-tumour efficiency: The potential for targeting reactive oxygen species","volume":"9","author":"Chasara","year":"2023","journal-title":"Heliyon"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Allegra, A., Gioacchino, M.D., Tonacci, A., Petrarca, C., and Gangemi, S. (2021). Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective. Nanomaterials, 11.","DOI":"10.3390\/nano11112792"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2174\/187152011796817682","article-title":"Nanoparticles in oncology: The new theragnostic molecules","volume":"11","author":"Allegra","year":"2011","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"650587","DOI":"10.3389\/fchem.2021.650587","article-title":"Reactive oxygen species-based nanomaterials for cancer therapy","volume":"9","author":"Li","year":"2021","journal-title":"Front. Chem."},{"key":"ref_227","first-page":"32","article-title":"Potential therapeutic applications of oblimersen in CLL","volume":"18","author":"Koziner","year":"2004","journal-title":"Oncology"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood-2012-01-407742","article-title":"Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia","volume":"121","author":"Yu","year":"2013","journal-title":"Blood"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood.2018882290","article-title":"ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model","volume":"134","author":"Chiang","year":"2019","journal-title":"Blood"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1039\/C3CC47512C","article-title":"Engineering ultrasmall water soluble gold and silver nanoclusters for biomedical applications","volume":"50","author":"Luo","year":"2014","journal-title":"Chem. Commun."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1039\/C5NR00857C","article-title":"Engineering noble metal nanomaterials for environmental applications","volume":"7","author":"Li","year":"2015","journal-title":"Nanoscale"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"12095","DOI":"10.1039\/C6NR02750D","article-title":"Peptide protected gold clusters: Chemical synthesis and biomedical applications","volume":"8","author":"Yuan","year":"2016","journal-title":"Nanoscale"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"21108","DOI":"10.1021\/acsami.1c05550","article-title":"Gold Cluster Capped with a BCL-2 Antagonistic Peptide Exerts Synergistic Antitumor Activity in Chronic Lymphocytic Leukemia Cells","volume":"13","author":"Yao","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41467-017-00954-1","article-title":"Homo-PROTACs: Bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation","volume":"8","author":"Maniaci","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","article-title":"Proteasomal and autophagic degradation systems","volume":"86","author":"Dikic","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","article-title":"Targeted protein degradation: Elements of PROTAC design","volume":"50","author":"Paiva","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ebiom.2018.09.005","article-title":"Small-molecule PROTACs: An Emerging and Promising Approach for the Development of Targeted Therapy Drugs","volume":"36","author":"An","year":"2018","journal-title":"eBioMedicine"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-022-01258-8","article-title":"A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.chembiol.2018.11.006","article-title":"Homo-log-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML","volume":"26","author":"Brand","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nchembio.2329","article-title":"Structural Basis of PROTAC Cooperative Recognition for Selective Protein Degradation","volume":"13","author":"Gadd","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2013-07-515361","article-title":"Bruton\u2019s tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)","volume":"123","author":"Woyach","year":"2014","journal-title":"Blood"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/PPO.0000000000000412","article-title":"BTK Inhibitors: Present and Future","volume":"25","author":"Burger","year":"2019","journal-title":"Cancer J."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"131","DOI":"10.37349\/etat.2020.00009","article-title":"Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors","volume":"1","author":"Arthur","year":"2020","journal-title":"Explor. Target. Anti-Tumor Ther."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Jaime-Figueroa, S., Buhimschi, A.D., Toure, M., Hines, J., and Crews, C.M. (2020). Design, synthesis and biological evaluation of Proteolysis Targeting Chimeras (PROTACs) as a BTK degraders with improved pharmacokinetic properties. Bioorg. Med. Chem. Lett., 30.","DOI":"10.1016\/j.bmcl.2019.126877"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Anwar, Z., Ali, M.S., Galvano, A., Perez, A., La Mantia, M., Bukhari, I., and Swiatczak, B. (2022). Protacs: The future of leukemia therapeutics. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.851087"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"11734","DOI":"10.1021\/jacs.9b13907","article-title":"Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACs","volume":"142","author":"Gabizon","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1021\/acs.biochem.8b00391","article-title":"Targeting the C481S ibrutinib-resistance mutation in Bruton\u2019s tyrosine kinase using PROTAC-mediated degradation","volume":"57","author":"Buhimschi","year":"2018","journal-title":"Biochemistry"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41422-018-0055-1","article-title":"PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies","volume":"28","author":"Sun","year":"2018","journal-title":"Cell Res."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.chembiol.2017.09.010","article-title":"Lessons in PROTAC design from selective degradation with a promiscuous warhead","volume":"25","author":"Bondeson","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.chembiol.2017.10.005","article-title":"A chemo-proteomic approach to query the degradable kinome using a multi-kinase degrader","volume":"25","author":"Huang","year":"2018","journal-title":"Cell Chem. Biol."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/13\/4\/475\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:29:12Z","timestamp":1760106552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/13\/4\/475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":250,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["antiox13040475"],"URL":"https:\/\/doi.org\/10.3390\/antiox13040475","relation":{},"ISSN":["2076-3921"],"issn-type":[{"type":"electronic","value":"2076-3921"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}